Results 31 to 40 of about 728,039 (351)

Exosomal transfer of long non-coding RNA SBF2-AS1 enhances chemoresistance to temozolomide in glioblastoma

open access: yesJournal of experimental & clinical cancer research : CR, 2019
Acquired drug resistance is a constraining factor in clinical treatment of glioblastoma (GBM). However, the mechanisms of chemoresponsive tumors acquire therapeutic resistance remain poorly understood.
Zhuoran Zhang   +5 more
semanticscholar   +1 more source

Long non-coding RNA NEAT1 promotes bone metastasis of prostate cancer through N6-methyladenosine

open access: yesMolecular Cancer, 2020
Background N6-methyladenosine (m6A) is the most prevalent messenger RNA modification in mammalian cells. However, the disease relevant function of m6A on specific oncogenic long non-coding RNAs (ncRNAs) is not well understood. Methods We analyzed the m6A
Simeng Wen   +5 more
semanticscholar   +1 more source

Human cancer long non-coding RNA transcriptomes. [PDF]

open access: yesPLoS ONE, 2011
Once thought to be a part of the 'dark matter' of the genome, long non-coding RNAs (lncRNAs) are emerging as an integral functional component of the mammalian transcriptome.
Ewan A Gibb   +10 more
doaj   +1 more source

Identification and function of long non-coding RNA [PDF]

open access: yes, 2013
Long non-coding (lnc) RNAs are defined as non-protein coding RNAs distinct from housekeeping RNAs such as tRNAs, rRNAs, and snRNAs, and independent from small RNAs with specific molecular processing machinery such as micro- or piwi-RNAs.
Ernst, Carl, Morton, Cynthia C.
core   +2 more sources

LncRNADisease 2.0: an updated database of long non-coding RNA-associated diseases

open access: yesNucleic Acids Res., 2018
Mounting evidence suggested that dysfunction of long non-coding RNAs (lncRNAs) is involved in a wide variety of diseases. A knowledgebase with systematic collection and curation of lncRNA-disease associations is critically important for further examining
Zhenyu Bao   +5 more
semanticscholar   +1 more source

An autophagy‐related long non‐coding RNA signature for glioma

open access: yesFEBS Open Bio, 2019
Glioma is one of the most common types of malignant primary central nervous system tumor, and prognosis for this disease is poor. As autophagic drugs have been reported to induce glioma cell death, we investigated the potential prognostic role of ...
Fangkun Luan   +7 more
doaj   +1 more source

Therapeutic role of long non-coding RNA TCONS_00019174 in depressive disorders is dependent on Wnt/$\beta$-catenin signaling pathway [PDF]

open access: yesJournal of Integrative Neuroscience, 2018
Chronic stress is one of the major causes that lead to major depressive disorder, which is a prevalent mood disorder worldwide. Many patients with major depressive disorder do not benefit from available medication due to the complex etiology of the ...
Xinqiang Ni, Yingzhao Liao, Limin Li, Xiaoli Zhang, Zhengzhi Wu
doaj   +1 more source

A long non-coding RNA protects the heart from pathological hypertrophy [PDF]

open access: yes, 2014
The role of long noncoding RNA (lncRNA) in adult hearts is unknownalso unclear is how lncRNA modulates nucleosome remodeling. An estimated 70% of mouse genes undergo antisense transcription, including myosin heavy chain 7 (Myh7) that encodes molecular ...
Ashley, Euan   +18 more
core   +5 more sources

Non-coding RNAs and glioblastoma: Insight into their roles in metastasis

open access: yesMolecular Therapy: Oncolytics, 2022
Glioma, also known as glioblastoma multiforme (GBM), is the most prevalent and most lethal primary brain tumor in adults. Gliomas are highly invasive tumors with the highest death rate among all primary brain malignancies.
Seyed Mojtaba Mousavi   +10 more
doaj   +1 more source

Regulation of Peripheral Myelination through Transcriptional Buffering of Egr2 by an Antisense Long Non-coding RNA [PDF]

open access: yes, 2017
Precise regulation of Egr2 transcription is fundamentally important to the control of peripheral myelination. Here, we describe a long non-coding RNA antisense to the promoter of Egr2 (Egr2-AS-RNA).
Langer, Robert S   +6 more
core   +2 more sources

Home - About - Disclaimer - Privacy